Literature DB >> 29050435

Immune-enhancing activity of phosvitin by stimulating the production of pro-inflammatory mediator.

J H Lee1, S H Moon2, H S Kim1, E Park3, D U Ahn4, H D Paik1.   

Abstract

Egg yolk phosvitin is one of the most phosphorylated proteins in nature, and the extraordinarily high concentration of phosphate groups in its structure provides a strong metal-binding ability. Phosvitin is known to possess various functional activities, including metal-chelating, antioxidant, emulsifying, antimicrobial, and cytotoxic activities. However, little is known about the immune-enhancing activity of phosvitin. The objective of this study was to evaluate the immune-enhancing activity of phosvitin in murine RAW 264.7 macrophages. Griess reagents and quantitative real-time PCR were used to determine the effect of phosvitin (at 12.5, 25, 50, and 100 μg/mL) on the levels of pro-inflammatory mediators NO and inducible nitric oxide synthase (iNOS), cytokines TNF-α and IL-1β in RAW 264.7 macrophages. The effect of phosvitin on the phagocytic activity of RAW 264.7 macrophages was also measured using the Neutral-Red Uptake method. Lipopolysaccharides was used as a positive control. Phosvitin significantly (P < 0.05) increased the production of NO in RAW 264.7 macrophages in a dose-dependent manner, but did not show any cytotoxicity. The amounts of NO produced were 3.47, 7.12, 10.23, and 14.57 μM in 12.5 to 100 μg/mL range of phosvitin (control: 0.46 μM). Compared with the untreated group, phosvitin treatment at a 100 μg/mL level increased the production of NO by 31.67 times. Phosvitin also significantly increased the mRNA expression of the RAW 264.7 macrophages: 100 μg/mL of phosvitin treatment increased the expression of mRNA for iNOS, TNF-α, and IL-1β by 46.25, 9.09, and 85.18 times of the control, respectively. The phagocytic activity of RAW 264.7 macrophages was also increased significantly by phosvitin treatment. These results demonstrated that phosvitin dramatically improved the immune functions RAW 264.7 macrophages by enhancing the production of immune mediators and increasing phagocytic activity. Therefore, phosvitin has a potential to be used as an immune-enhancing agent by food or nutraceutical industries.
© 2017 Poultry Science Association Inc.

Entities:  

Keywords:  RAW 264.7 macrophage; egg yolk protein; immune-enhancing activity; phosvitin

Mesh:

Substances:

Year:  2017        PMID: 29050435     DOI: 10.3382/ps/pex205

Source DB:  PubMed          Journal:  Poult Sci        ISSN: 0032-5791            Impact factor:   3.352


  6 in total

1.  Ovalbumin Hydrolysates Inhibit Nitric Oxide Production in LPS-induced RAW 264.7 Macrophages.

Authors:  Hyun Suk Kim; Jae Hoon Lee; Sun Hee Moon; Dong Uk Ahn; Hyun-Dong Paik
Journal:  Food Sci Anim Resour       Date:  2020-03-01

2.  Egg Yolk Protein Water Extracts Modulate the Immune Response in BALB/c Mice with Immune Dysfunction Caused by Forced Swimming.

Authors:  Mijoo Choi; Jae-Hoon Lee; Yun-Jung Lee; Hyun-Dong Paik; Eunju Park
Journal:  Foods       Date:  2022-01-04

3.  Immune-Enhancing Effect of Heat-Treated Levilactobacillus brevis KU15159 in RAW 264.7 Cells.

Authors:  Chang-Hoon Hwang; Kee-Tae Kim; Na-Kyoung Lee; Hyun-Dong Paik
Journal:  Probiotics Antimicrob Proteins       Date:  2022-09-30       Impact factor: 5.265

4.  Glutathione Induced Immune-Stimulatory Activity by Promoting M1-Like Macrophages Polarization via Potential ROS Scavenging Capacity.

Authors:  Da Hye Kwon; Hyesook Lee; Cheol Park; Su-Hyun Hong; Sang Hoon Hong; Gi-Young Kim; Hee-Jae Cha; Suhkmann Kim; Heui-Soo Kim; Hye-Jin Hwang; Yung Hyun Choi
Journal:  Antioxidants (Basel)       Date:  2019-09-18

Review 5.  The Influence of Nutrients on Inflammatory Bowel Diseases.

Authors:  Sara Jarmakiewicz-Czaja; Dominika Piątek; Rafał Filip
Journal:  J Nutr Metab       Date:  2020-02-27

Review 6.  Anticancer and immunomodulatory activity of egg proteins and peptides: a review.

Authors:  J H Lee; H-D Paik
Journal:  Poult Sci       Date:  2019-12-01       Impact factor: 3.352

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.